The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.
Vikram Sadineni
Advertisement
Vikram Sadineni is senior research investigator, Department of Drug Product Science & Technology R&D, Bristol-Myers Squibb, New Brunswick, NJ 08903.
Articles by Vikram Sadineni
Advertisement
Latest Updated Articles
Implications of Trace Levels of Redox-Active Metals in Drug-Product FormulationPublished: April 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
2
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
3
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
4
BioPharma By the Numbers: Bioprocess Hiring Creating Capacity Constraints
5
